HLA-E-restricted HIV-1-specific CD8+ T cell responses in natural infection.
Amino Acid Sequence
Antigen Presentation
CD8-Positive T-Lymphocytes
/ immunology
Cell Line
HIV Infections
/ genetics
HIV Seronegativity
/ immunology
HIV-1
/ genetics
HLA-B Antigens
/ immunology
Histocompatibility Antigens Class I
/ immunology
Humans
Immunodominant Epitopes
In Vitro Techniques
Receptors, Antigen, T-Cell, alpha-beta
/ genetics
gag Gene Products, Human Immunodeficiency Virus
/ genetics
HLA-E Antigens
Infectious disease
T cells
Journal
The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877
Informations de publication
Date de publication:
16 08 2021
16 08 2021
Historique:
received:
22
02
2021
accepted:
01
07
2021
pubmed:
7
7
2021
medline:
9
11
2021
entrez:
6
7
2021
Statut:
ppublish
Résumé
CD8+ T cell responses restricted by MHC-E, a nonclassical MHC molecule, have been associated with protection in an SIV/rhesus macaque model. The biological relevance of HLA-E-restricted CD8+ T cell responses in HIV infection, however, remains unknown. In this study, CD8+ T cells responding to HIV-1 Gag peptides presented by HLA-E were analyzed. Using in vitro assays, we observed HLA-E-restricted T cell responses to what we believe to be a newly identified subdominant Gag-KL9 as well as a well-described immunodominant Gag-KF11 epitope in T cell lines derived from chronically HIV-infected patients and also primed from healthy donors. Blocking of the HLA-E/KF11 binding by the B7 signal peptide resulted in decreased CD8+ T cell responses. KF11 presented via HLA-E in HIV-infected cells was recognized by antigen-specific CD8+ T cells. Importantly, bulk CD8+ T cells obtained from HIV-infected individuals recognized infected cells via HLA-E presentation. Ex vivo analyses at the epitope level showed a higher responder frequency of HLA-E-restricted responses to KF11 compared with KL9. Taken together, our findings of HLA-E-restricted HIV-specific immune responses offer intriguing and possibly paradigm-shifting insights into factors that contribute to the immunodominance of CD8+ T cell responses in HIV infection.
Identifiants
pubmed: 34228645
pii: e148979
doi: 10.1172/JCI148979
pmc: PMC8363272
doi:
pii:
Substances chimiques
HLA-B Antigens
0
HLA-B57 antigen
0
Histocompatibility Antigens Class I
0
Immunodominant Epitopes
0
Receptors, Antigen, T-Cell, alpha-beta
0
gag Gene Products, Human Immunodeficiency Virus
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIAID NIH HHS
ID : R01 AI102663
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI162168
Pays : United States
Références
J Transl Med. 2016 Mar 01;14:62
pubmed: 26928826
Antivir Ther. 2005;10(1):95-107
pubmed: 15751767
PLoS One. 2012;7(9):e46120
pubmed: 23049954
Mol Immunol. 2013 Jan;53(1-2):126-31
pubmed: 22898188
J Immunol. 2006 Jun 1;176(11):6690-701
pubmed: 16709828
Immunity. 2015 Sep 15;43(3):591-604
pubmed: 26362266
Hum Immunol. 2004 May;65(5):437-45
pubmed: 15172443
Nat Commun. 2018 Aug 7;9(1):3137
pubmed: 30087334
J Exp Med. 2008 Mar 17;205(3):725-35
pubmed: 18332182
J Virol. 2019 Sep 12;93(19):
pubmed: 31315990
Clin Vaccine Immunol. 2009 Feb;16(2):147-55
pubmed: 19091991
Eur J Immunol. 2002 Apr;32(4):936-44
pubmed: 11920559
J Virol. 2020 Jan 6;94(2):
pubmed: 31645444
Sci Immunol. 2021 Mar 25;6(57):
pubmed: 33766849
PLoS Pathog. 2019 Aug 9;15(8):e1007970
pubmed: 31398241
Curr Opin Immunol. 2017 Aug;47:52-56
pubmed: 28734175
PLoS One. 2016 Feb 10;11(2):e0147812
pubmed: 26863315
Clin Vaccine Immunol. 2010 Sep;17(9):1305-14
pubmed: 20660136
Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10896-901
pubmed: 12960383
J Leukoc Biol. 2015 Apr;97(4):761-7
pubmed: 25713086
Science. 2013 May 24;340(6135):1237874
pubmed: 23704576
Nature. 2011 May 26;473(7348):523-7
pubmed: 21562493
Nucleic Acids Res. 2013 Jan;41(Database issue):D1234-40
pubmed: 23180793
Nature. 2013 Oct 3;502(7469):100-4
pubmed: 24025770
Curr Pharm Des. 2009;15(28):3336-44
pubmed: 19860683
Sci Immunol. 2021 Mar 25;6(57):
pubmed: 33766848
PLoS Pathog. 2018 Apr 30;14(4):e1007041
pubmed: 29709038
Nat Immunol. 2006 Mar;7(3):256-64
pubmed: 16474394
Eur J Immunol. 2001 Dec;31(12):3687-93
pubmed: 11745389
AIDS. 2002 Feb 15;16(3):321-8
pubmed: 11834942
J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):132-40
pubmed: 21637109
Placenta. 2017 Jan;49:33-36
pubmed: 28012452
PLoS One. 2013;8(3):e59210
pubmed: 23527138
J Immunol. 2005 Feb 15;174(4):2116-23
pubmed: 15699142
J Virol. 2021 Jul 26;95(16):e0016021
pubmed: 34076482
Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5199-204
pubmed: 9560253
Retrovirology. 2013 Dec 12;10:152
pubmed: 24330837
J Immunol. 2018 Jul 1;201(1):113-123
pubmed: 29743316
Immunol Lett. 2018 Oct;202:65-72
pubmed: 30172717
PLoS Pathog. 2016 Feb 01;12(2):e1005421
pubmed: 26828202
Mol Immunol. 2020 Apr;120:101-112
pubmed: 32113130
J Infect Dis. 2009 Nov 1;200(9):1397-401
pubmed: 19780673
Eur J Immunol. 2005 Nov;35(11):3240-7
pubmed: 16224817
Science. 1999 Feb 5;283(5403):857-60
pubmed: 9933172
Science. 2021 Apr 30;372(6541):
pubmed: 33766941
Eur J Immunol. 2018 Feb;48(2):293-305
pubmed: 29124751
PLoS One. 2015 Aug 24;10(8):e0135972
pubmed: 26302084
Eur J Immunol. 2010 Jul;40(7):1950-62
pubmed: 20432235
Front Immunol. 2014 Apr 22;5:180
pubmed: 24795723
J Exp Med. 1999 Mar 15;189(6):991-8
pubmed: 10075982
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Science. 2016 Feb 12;351(6274):714-20
pubmed: 26797147
J Virol. 2013 Mar;87(5):2628-38
pubmed: 23255798
J Immunol. 1989 May 1;142(9):3320-8
pubmed: 2785140
PLoS Pathog. 2015 Mar 24;11(3):e1004671
pubmed: 25803478
J Immunol. 2020 Nov 15;205(10):2861-2872
pubmed: 33020145
Immunology. 2014 Jan;141(1):27-38
pubmed: 23941420
PLoS One. 2012;7(11):e50951
pubmed: 23226431
Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14666-70
pubmed: 9405670
J Biol Chem. 2003 Feb 14;278(7):5082-90
pubmed: 12411439
Immunogenetics. 2016 Jan;68(1):29-41
pubmed: 26552660
J Virol. 2007 Mar;81(5):2440-8
pubmed: 17182686
Blood. 2007 Jul 1;110(1):201-10
pubmed: 17371945
J Immunol. 2018 Jan 1;200(1):49-60
pubmed: 29150562
J Exp Med. 2002 Dec 2;196(11):1403-14
pubmed: 12461076
Nature. 2017 Jul 6;547(7661):89-93
pubmed: 28636592
J Immunol. 1998 May 15;160(10):4951-60
pubmed: 9590243
Immunology. 2007 Sep;122(1):90-7
pubmed: 17472719
J Immunol Res. 2016;2016:2695396
pubmed: 27699181
Eur J Immunol. 2020 Dec;50(12):2075-2091
pubmed: 32716529
Retrovirology. 2018 Jul 3;15(1):46
pubmed: 29970102
J Infect Dis. 2019 Oct 8;220(10):1620-1628
pubmed: 31301135
PLoS One. 2017 Nov 27;12(11):e0188288
pubmed: 29176828
J Immunol. 2020 Apr 15;204(8):2169-2176
pubmed: 32161099